» Articles » PMID: 12193470

Phosphoinositide 3-kinase Mediates Enhanced Spontaneous and Agonist-induced Contraction in Aorta of Deoxycorticosterone Acetate-salt Hypertensive Rats

Overview
Journal Circ Res
Date 2002 Aug 24
PMID 12193470
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Arteries from deoxycorticosterone acetate (DOCA)-salt and N(omega)-nitro-L-arginine (L-NNA) hypertensive but not normotensive rats develop spontaneous tone. LY294002 and wortmannin, phosphoinositide 3-kinase (PI3-kinase) inhibitors, eliminate spontaneous tone. We hypothesized that PI3-kinase protein and/or activity was increased in hypertension and contributed to the observed enhanced contractility. PI3-kinase activity assays revealed 2-fold higher activity in thoracic aorta from DOCA-salt [systolic blood pressure (SBP)=184+/-5 mm Hg] compared with sham rats (SBP=111+/-2 mm Hg). Western analyses of aortic homogenates revealed the presence of p85alpha, p110alpha, p110beta, and p110delta but not p110gamma PI3-kinase subunits; p110delta protein was elevated in aorta of hypertensive rats as compared with sham. Aortic homogenates from L-NNA rats also had elevated p110beta protein density, but neither L-NNA nor DOCA-salt had differences in p85alpha and p110alpha. Total Akt density was unaltered, but pAkt was significantly lower in homogenates from DOCA-salt rats. LY294002 (20 micromol/L) and nifedipine (50 nmol/L) abolished Ca2+-induced spontaneous tone in aorta from DOCA-salt rats. However, LY294002 did not alter BayK8644-induced contraction, indicating that LY294002 does not inhibit L-type Ca2+ channels directly. PTEN (phosphatase and tensin homolog) and pPTEN were expressed but not different in aorta from DOCA-salt and sham rats. LY294002 corrected the enhanced contraction to KCl and norepinephrine in aorta from DOCA-salt rats. These data support an increase in PI3-kinase activity and p110delta density in aorta from L-NNA and DOCA-salt rats. Importantly, this increase contributes to the enhanced contractility observed in two models of hypertension.

Citing Articles

Cardiotoxicity Induced by Protein Kinase Inhibitors in Patients with Cancer.

Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, Korman M, Puskulluoglu M Int J Mol Sci. 2022; 23(5).

PMID: 35269958 PMC: 8910876. DOI: 10.3390/ijms23052815.


Prenatal inflammation exposure-programmed hypertension exhibits multi-generational inheritance via disrupting DNA methylome.

Guan X, Dan G, Yang Y, Ji Y, Lai W, Wang F Acta Pharmacol Sin. 2021; 43(6):1419-1429.

PMID: 34593973 PMC: 8482360. DOI: 10.1038/s41401-021-00772-8.


Role of PI3K/Akt signaling pathway in cardiac fibrosis.

Qin W, Cao L, Massey I Mol Cell Biochem. 2021; 476(11):4045-4059.

PMID: 34244974 DOI: 10.1007/s11010-021-04219-w.


Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma.

Lenz G, Hawkes E, Verhoef G, Haioun C, Lim S, Heo D Leukemia. 2020; 34(8):2184-2197.

PMID: 32060403 PMC: 7387311. DOI: 10.1038/s41375-020-0743-y.


PI3K inhibitors in thrombosis and cardiovascular disease.

Durrant T, Hers I Clin Transl Med. 2020; 9(1):8.

PMID: 32002690 PMC: 6992830. DOI: 10.1186/s40169-020-0261-6.